These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15932907)

  • 1. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.
    Rothenbacher D; Brenner H; März W; Koenig W
    Eur Heart J; 2005 Aug; 26(16):1640-6. PubMed ID: 15932907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin and coronary heart disease: a prospective study and meta-analysis.
    Sattar N; Wannamethee G; Sarwar N; Tchernova J; Cherry L; Wallace AM; Danesh J; Whincup PH
    Circulation; 2006 Aug; 114(7):623-9. PubMed ID: 16894037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
    Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study.
    Luc G; Empana JP; Morange P; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Evans A; Kee F; Bingham A; Machez E; Ducimetiere P
    Int J Obes (Lond); 2010 Jan; 34(1):118-26. PubMed ID: 19823188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany.
    Koenig W; Khuseyinova N; Baumert J; Meisinger C; Löwel H
    J Am Coll Cardiol; 2006 Oct; 48(7):1369-77. PubMed ID: 17010797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses.
    Hashimoto N; Kanda J; Nakamura T; Horie A; Kurosawa H; Hashimoto T; Sato K; Kushida S; Suzuki M; Yano S; Iwai R; Takahashi H; Yoshida S
    Metabolism; 2006 Dec; 55(12):1653-7. PubMed ID: 17142139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
    Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
    Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma adiponectin: a predictor of coronary heart disease in hemodialysis patients--a Japanese prospective eight-year study.
    Takemoto F; Katori H; Sawa N; Hoshino J; Suwabe T; Nakanishi S; Arai S; Fukuda S; Kodaka K; Shimada M; Yamazaki C; Yokoyama K; Nakano Y; Funahashi T; Ubara Y; Yamada A; Takaichi K; Uchida S
    Nephron Clin Pract; 2009; 111(1):c12-20. PubMed ID: 19052467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
    Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G
    Angiology; 2008; 59(1):26-35. PubMed ID: 18319219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation.
    Divecha H; Sattar N; Rumley A; Cherry L; Lowe GD; Sturrock R
    Clin Sci (Lond); 2005 Aug; 109(2):171-6. PubMed ID: 15801904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum RANTES concentrations with established cardiovascular risk markers in middle-aged subjects.
    Koh SJ; Kim JY; Hyun YJ; Park SH; Chae JS; Park S; Kim JS; Youn JC; Jang Y; Lee JH
    Int J Cardiol; 2009 Feb; 132(1):102-8. PubMed ID: 18190991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.
    Gannagé-Yared MH; Fares F; Semaan M; Khalife S; Jambart S
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):652-8. PubMed ID: 16712667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study.
    Yudkin JS; May M; Elwood P; Yarnell JW; Greenwood R; Davey Smith G;
    Diabetologia; 2002 Mar; 45(3):327-36. PubMed ID: 11914737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
    Mertens I; Ballaux D; Funahashi T; Matsuzawa Y; Van der Planken M; Verrijken A; Ruige JB; Van Gaal LF
    Thromb Haemost; 2005 Dec; 94(6):1190-5. PubMed ID: 16411393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum alanine aminotransferase is associated with serum adiponectin, C-reactive protein and apolipoprotein B in young healthy men.
    Kazumi T; Kawaguchi A; Hirano T; Yoshino G
    Horm Metab Res; 2006 Feb; 38(2):119-24. PubMed ID: 16523413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease.
    Chen GL; Liu LW; Xie S; Liu H; Liu YQ; Li YS
    Chin Med J (Engl); 2010 Mar; 123(6):658-63. PubMed ID: 20368082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
    Imhof A; Rothenbacher D; Khuseyinova N; Hoffmeister A; Maerz W; Nauck M; Scharnagl H; Koenig W; Brenner H
    Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):362-70. PubMed ID: 14663298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma C-reactive protein in subjects with hypo/hyperalphalipoproteinemias.
    Pirro M; Siepi D; Lupattelli G; Roscini AR; Schillaci G; Gemelli F; Vaudo G; Marchesi S; Pasqualini L; Mannarino E
    Metabolism; 2003 Apr; 52(4):432-6. PubMed ID: 12701054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk.
    Blanco-Colio LM; Martín-Ventura JL; Gómez-Guerrero C; Masramon X; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Egido J
    Eur J Pharmacol; 2008 May; 586(1-3):259-65. PubMed ID: 18374327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.